December 16, 2019, Foster City, CA, Mirum Pharmaceuticals, Inc. (Nasdaq: MIRM), a biopharmaceutical company focused on the development and commercialization of novel therapies for debilitating liver diseases, today announced the...
Reneo Pharmaceuticals
Reneo Pharmaceuticals is a clinical-stage start-up company, co-founded by Pappas Capital, focused on developing treatments for rare metabolic disorders
